Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 2, 2013, Pages 137-140

  Khalaf, Waleed F ^a   Caldwell, Meghan E ^a   Reddy, Nishitha ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BRENTUXIMAB VEDOTIN; CARBOPLATIN; CD3 ANTIGEN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; HEMOGLOBIN BETA CHAIN; IFOSFAMIDE; NAVELBINE; PREDNISONE; ROMIDEPSIN; VINCRISTINE;

ADULT; ALBUMIN BLOOD LEVEL; ARTERY THROMBOSIS; ARTICLE; BACKACHE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOSCOPY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; FEBRILE NEUTROPENIA; FEVER; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTESTINE BIOPSY; INTESTINE ULCER; IRON DEFICIENCY ANEMIA; LEUKOPENIA; MALE; MEAN CORPUSCULAR VOLUME; MESENTERY LYMPH NODE; MICROCYTIC ANEMIA; MULTIPLE CYCLE TREATMENT; MULTIPLE PULMONARY NODULES; NEUROPATHY; PERITONEAL DISEASE; REMISSION; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; THROMBOCYTOSIS; VENOUS THROMBOEMBOLISM; WEIGHT REDUCTION;

EID: 84874601684     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0021     Document Type: Article

References (15)

1. Sharaiha RZ, Lebwohl B, Reimers L, et al. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer 2012;118:3786-3792.
2. Wright DH. Enteropathy associated T cell lymphoma. Cancer Surv 1997;30:249-261.
3. Murray A, Cuevas EC, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995;146:509-519.
4. Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803.
5. Novakovic BJ, Novakovic S, Frkovic-Grazio S. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas. Oncol Rep 2006;16:191-195.
6. Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal Non-Hodgkin's Lymphoma. J Clin Oncol 2003;21:2740-2746.
7. Egan LJ, Walsh SV, Stevens FM, et al. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 1995;21:123-129.
8. Wohrer S, Chott A, Drach J, et al. Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Ann Oncol 2004;15:1680-1683.
9. Sieniawski M, Angamuthu N, Boyd K, et al. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 2010;115:3664-3670.
10. Delabie J, Holte H, Vose JM, et al. Enteropathy-associated T-cell lymphoma: clinical and histological findings from the International Peripheral T-Cell Lymphoma Project. Blood 2011;118:148-155.
11. Raderer M, Troch M, Kiesewetter B, et al. Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis. Ann Hematol 2012;91:57-61.
12. Senter PD, Sievers EL. The discovery and development of brentuximab vedotin for use in relapsed hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat Biotechnol 2012;30:631-637.
13. Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 2010;363:1812-1821.
14. Pro B, Advani R, Brice P, et al. Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol 2012;30:2190-2196.
15. Zelenetz AD, Abramson JS, Advani RH, et al. NCCN Clinical Practice Guidelines in Oncology for Non-Hodgkin's Lymphomas. Version 1.2013. Available at: NCCN.org. Accessed January 16, 2013.